Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study
- PMID: 9243105
- DOI: 10.1007/s001250050756
Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study
Abstract
Although insulin resistance and decreased insulin secretion are characteristic of established non-insulin-dependent diabetes mellitus (NIDDM), which of these metabolic abnormalities is the primary determinant of NIDDM is still controversial. A disproportionate increase in the proinsulin to insulin ratio has been proposed as a marker of compromised insulin secretion. We examined the association of fasting immunoreactive insulin (which cross-reacts with proinsulin), specific insulin (which does not cross-react with proinsulin), total immunoreactive proinsulin (or insulin precursors), and the fasting proinsulin/specific insulin ratio to the risk of developing NIDDM in the 3.25-year follow-up of the Mexico City Diabetes Study. These measurements were made in 85 subjects who subsequently converted to NIDDM (prediabetic subjects) and in 85 age and gender matched subjects who remained non-diabetic at follow-up (control subjects). Immunoreactive insulin, proinsulin and the proinsulin/specific insulin ratio were significantly higher in prediabetic than in control subjects. However, the relation between specific insulin and the development of NIDDM was weaker than for proinsulin or immunoreactive insulin. After further adjustment for obesity, body fat distribution and glucose tolerance status, proinsulin and the proinsulin/specific insulin ratio, but not specific or immunoreactive insulin, predicted conversion to NIDDM. A high proinsulin/specific insulin ratio predicted conversion to NIDDM both in subjects with normal and those with impaired glucose tolerance at baseline. We conclude that in prediabetic subjects increased proinsulin, a marker of islet cell distress or compromised insulin secretion, is associated with rapid conversion (within 3.25 years) to NIDDM even in obese populations.
Similar articles
-
Are risk factors for conversion to NIDDM similar in high and low risk populations?Diabetologia. 1997 Jan;40(1):62-6. doi: 10.1007/s001250050643. Diabetologia. 1997. PMID: 9028719
-
Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.Diabet Med. 1996 Sep;13(9 Suppl 6):S63-6. Diabet Med. 1996. PMID: 8894485
-
Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.Diabetologia. 1996 Jan;39(1):113-8. doi: 10.1007/BF00400421. Diabetologia. 1996. PMID: 8720611
-
[Worsening factors for the progression of impaired glucose tolerance to diabetes mellitus learning from prospective studies].Nihon Rinsho. 1996 Oct;54(10):2725-32. Nihon Rinsho. 1996. PMID: 8914435 Review. Japanese.
-
Insulin secretion in obese and non-obese NIDDM.Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S27-37. doi: 10.1016/0168-8227(95)01083-p. Diabetes Res Clin Pract. 1995. PMID: 8529516 Review.
Cited by
-
Proinsulin to insulin ratio is associated with incident type 2 diabetes but not with vascular complications in the KORA F4/FF4 study.BMJ Open Diabetes Res Care. 2020 May;8(1):e001425. doi: 10.1136/bmjdrc-2020-001425. BMJ Open Diabetes Res Care. 2020. PMID: 32423965 Free PMC article.
-
Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus.Drugs. 2005;65(1):1-13. doi: 10.2165/00003495-200565010-00001. Drugs. 2005. PMID: 15610048 Review.
-
Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients.Arthritis Res Ther. 2013 Jan 22;15(1):R17. doi: 10.1186/ar4149. Arthritis Res Ther. 2013. PMID: 23339356 Free PMC article.
-
Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men--report from 27 years of follow-up study.Diabetologia. 2003 Jan;46(1):20-6. doi: 10.1007/s00125-002-0995-2. Epub 2003 Jan 8. Diabetologia. 2003. PMID: 12637978
-
Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).Diabetologia. 2011 Dec;54(12):3047-54. doi: 10.1007/s00125-011-2322-2. Epub 2011 Sep 30. Diabetologia. 2011. PMID: 21959959
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical